# Priapism: Classification and Emergency Management

## Introduction

Priapism is characterized by a persistent penile erection lasting more than four hours that occurs independently of sexual stimulation. It represents a urologic emergency, especially in the case of ischemic priapism, because prolonged ischemia within the corporal bodies leads to irreversible smooth muscle necrosis, fibrosis, and ultimately permanent erectile dysfunction. The term "priapism" originates from Priapus, the Greek god of fertility. A thorough understanding of its classification and underlying pathophysiology is crucial for timely and appropriate management.

## Classification

### Ischemic (Low-Flow, Veno-Occlusive) Priapism

Ischemic priapism accounts for over 95% of cases and results from a failure of venous outflow from the corpora cavernosa. This leads to trapped, stagnant, and deoxygenated blood within the corpora, causing progressive hypoxia, hypercarbia, and acidosis. These changes impair smooth muscle function and eventually cause necrosis. Clinically, the corpora cavernosa are fully rigid, while the corpus spongiosum and glans remain soft, which helps differentiate ischemic from non-ischemic priapism. Patients typically experience significant pain due to tissue ischemia. The extent of tissue damage is time-dependent: within the first four hours, smooth muscle dysfunction is reversible; between four and twelve hours, interstitial edema and endothelial damage develop; from twelve to twenty-four hours, thrombus formation and the onset of smooth muscle necrosis occur; between twenty-four and forty-eight hours, extensive necrosis and fibroblast-like transformation of smooth muscle take place; beyond forty-eight hours, fibrosis becomes irreversible, and the rate of erectile dysfunction approaches 90 to 100%.

| Duration | Pathologic Changes | Reversibility |
|---|---|---|
| 0-4 hours | Smooth muscle dysfunction | Reversible |
| 4-12 hours | Interstitial edema, endothelial damage | Partially reversible |
| 12-24 hours | Thrombus formation, early smooth muscle necrosis | Increasingly irreversible |
| 24-48 hours | Extensive necrosis, fibroblast-like transformation | Largely irreversible |
| >48 hours | Complete fibrosis | Irreversible; ED rate 90-100% |

### Non-Ischemic (High-Flow, Arterial) Priapism

Non-ischemic priapism is rare, comprising less than 5% of cases. It arises from unregulated arterial inflow into the corpora cavernosa, usually due to traumatic laceration of the cavernosal artery that creates a fistula between the artery and the lacunar spaces. This results in a partially rigid erection that is tumescent but not fully rigid and is typically non-tender. Unlike ischemic priapism, it is not a true emergency because there is no tissue ischemia, allowing for expectant management. It often follows perineal or penile trauma, such as straddle injuries or needle punctures.

### Stuttering (Recurrent Ischemic) Priapism

Stuttering priapism consists of recurrent episodes of ischemic priapism that are usually self-limiting, lasting one to three hours, but tend to increase in frequency and duration over time. It is strongly associated with sickle cell disease (SCD), affecting up to 42% of adult males with the condition. Each episode carries the risk of progressing to a prolonged, major ischemic event, necessitating a preventive management strategy.

## Etiology

### Ischemic Priapism

Sickle cell disease is the most common cause of ischemic priapism in children and young African American men, where sickling within the corpora leads to venous outflow obstruction. Various medications can also induce ischemic priapism. Intracavernosal injection therapies such as alprostadil, papaverine, and phentolamine are the most common causes in adults and are dose-dependent. Phosphodiesterase-5 inhibitors have been rarely implicated. Antipsychotics like trazodone, chlorpromazine, risperidone, and olanzapine can cause priapism through alpha-adrenergic antagonism. Anticoagulants such as heparin and warfarin, as well as recreational drugs including cocaine, marijuana, and alcohol, are additional contributors. Hematologic malignancies, particularly chronic myeloid leukemia and multiple myeloma, can also cause ischemic priapism. In 30 to 50% of adult cases, the cause remains idiopathic.

### Non-Ischemic Priapism

Non-ischemic priapism typically results from perineal or penile trauma that creates a fistula between the cavernosal artery and the lacunar spaces. It can also occur post-surgically after corporal shunting procedures performed for ischemic priapism. Rarely, congenital arteriovenous malformations are responsible.

<image>Comparative anatomic cross-section diagrams of the penis showing: (1) normal flaccid state with regulated arterial inflow and venous outflow, (2) ischemic priapism with occluded venous outflow, trapped deoxygenated blood in the corpora cavernosa, and soft corpus spongiosum/glans, and (3) non-ischemic priapism with a cavernosal artery fistula causing unregulated arterial inflow with partially rigid corpora and a labeled lacunar space arterial fistula</image>

## Diagnostic Evaluation

### History and Physical Examination

The duration of the erection is critical for prognosis and treatment planning. Pain is a distinguishing feature: ischemic priapism is painful, whereas non-ischemic priapism is typically painless. A history of sickle cell disease, use of medications such as intracavernosal injections or trazodone, trauma, and recreational drug use should be elicited. On examination, ischemic priapism presents with rigid corpora and a soft glans, while non-ischemic priapism shows a tumescent, partially rigid penis.

### Corporal Blood Gas Analysis

Aspiration of blood from the corpus cavernosum is the most important diagnostic test to differentiate ischemic from non-ischemic priapism. In ischemic priapism, the aspirated blood is dark, with a partial pressure of oxygen (pO2) less than 40 mmHg, partial pressure of carbon dioxide (pCO2) greater than 60 mmHg, and pH below 7.25, resembling venous blood. In contrast, non-ischemic priapism yields bright red blood with pO2 greater than 90 mmHg, pCO2 less than 40 mmHg, and pH between 7.35 and 7.45, similar to arterial blood. Normal mixed venous blood has intermediate values.

| Parameter | Ischemic (Low-Flow) | Non-Ischemic (High-Flow) | Normal Venous |
|---|---|---|---|
| Blood color | Dark | Bright red | Dark red |
| pO2 (mmHg) | <40 | >90 | ~40 |
| pCO2 (mmHg) | >60 | <40 | ~50 |
| pH | <7.25 | 7.35-7.45 | 7.35 |

### Imaging

Color Doppler ultrasound can confirm the diagnosis if blood gas analysis is equivocal. In ischemic priapism, cavernosal artery blood flow is absent or minimal, whereas in non-ischemic priapism, turbulent high-velocity flow is observed at the fistula site, often demonstrating a "yin-yang" sign at the pseudoaneurysm. Penile MRI may help differentiate viable from necrotic corporal tissue in prolonged ischemic priapism. Arteriography is used therapeutically in non-ischemic priapism for selective embolization.

### Laboratory Studies

Laboratory evaluation includes a complete blood count with differential to screen for leukemia, reticulocyte count, and sickle cell screening. Hemoglobin electrophoresis is indicated if sickle cell disease is suspected. Toxicology screening is useful when drug use is suspected, and coagulation studies are warranted if anticoagulant-related priapism is considered.

## Emergency Management of Ischemic Priapism

### Step 1: Corporal Aspiration and Irrigation

The initial intervention involves inserting a 16- to 18-gauge needle into the lateral aspect of the corpus cavernosum, typically at the 2-3 o’clock or 9-10 o’clock position, to avoid injury to the dorsal neurovascular bundle and ventral urethra. Dark blood is aspirated until bright red blood returns, indicating fresh oxygenated blood. The corpora are then irrigated with normal saline in 10-20 mL aliquots, aspirating after each injection. Aspiration alone resolves priapism in approximately 30 to 36% of cases.

### Step 2: Intracavernosal Sympathomimetic Injection

If aspiration and irrigation fail, intracavernosal injection of phenylephrine, an alpha-1 agonist, is administered. Phenylephrine is diluted by mixing 1 mL of the 10 mg/mL solution in 19 mL of normal saline to achieve a concentration of 500 mcg/mL. Doses of 100 to 500 mcg are injected every 3 to 5 minutes, with a maximum total dose of 1000 mcg (1 mg). Blood pressure and heart rate must be closely monitored due to risks of hypertensive crisis, reflex bradycardia, and cardiac arrhythmias. Caution is advised in patients with cardiovascular disease, uncontrolled hypertension, or those taking monoamine oxidase inhibitors. The combination of aspiration and phenylephrine injection achieves resolution in 70 to 80% of cases. Epinephrine should be avoided because its beta-adrenergic effects increase the risk of cardiovascular complications.

### Step 3: Surgical Shunting (If Medical Management Fails)

If medical management is unsuccessful, surgical shunting is indicated. Distal shunts are the first-line surgical option. The Winter shunt involves percutaneous insertion of a Tru-Cut biopsy needle through the glans into the corpus cavernosum to create a fistula between the corpus cavernosum and corpus spongiosum. The Ebbehoj shunt uses a scalpel blade inserted through the glans to create a window, while the T-shunt (Al-Husseini) involves a scalpel blade inserted through the glans with a 90-degree rotation to create a larger window, sometimes including corporal tunneling with a dilator.

Proximal shunts, such as the Quackels shunt, which creates an open incision at the perineum to form a window between the corpus cavernosum and corpus spongiosum, and the Grayhack shunt, which anastomoses the corpus cavernosum to the saphenous vein, are second-line options. These carry higher risks of urethral injury and fistula formation.

Early penile prosthesis implantation is increasingly recommended for ischemic priapism lasting more than 48 to 72 hours, where erectile dysfunction is inevitable. A malleable prosthesis is preferred initially and can be upsized to an inflatable device after three to six months. Early implantation avoids the corporal fibrosis and shortening that complicate delayed prosthesis placement.

<image>Stepwise management algorithm for ischemic priapism: initial assessment with corporal blood gas, first-line aspiration and irrigation, second-line intracavernosal phenylephrine injection with dosing protocol, distal shunt procedures (Winter, T-shunt) if medical management fails, proximal shunts for refractory cases, and early penile prosthesis consideration for priapism duration greater than 48-72 hours</image>

## Management of Non-Ischemic Priapism

Non-ischemic priapism often resolves spontaneously within days to weeks and does not require urgent intervention because there is no tissue ischemia. When intervention is necessary, selective arterial embolization performed by interventional radiology is the preferred treatment. This involves catheter-based embolization of the internal pudendal or cavernosal artery fistula using absorbable gelfoam, which is preferred over coils to minimize the risk of erectile dysfunction. The success rate of embolization ranges from 75 to 90%, although recurrence is possible and may require repeat procedures. Surgical ligation of the fistula is reserved for cases where embolization fails.

## Stuttering Priapism Prevention

Prevention of stuttering priapism includes self-injection of phenylephrine at home during acute episodes. Oral therapies for prophylaxis include pseudoephedrine at doses of 30 to 60 mg at bedtime, baclofen 10 to 20 mg three times daily as a GABA-B agonist, and finasteride 5 mg daily to reduce androgen-mediated erections. Hormonal suppression with gonadotropin-releasing hormone (GnRH) agonists or antagonists such as leuprolide or degarelix is considered a last resort. In patients with sickle cell disease, hydroxyurea reduces sickling episodes and thus priapism risk. Interestingly, low-dose daily phosphodiesterase-5 inhibitors may have a paradoxical benefit by regulating nitric oxide/cGMP signaling, though data are emerging.

## Key Clinical Pearls

Ischemic priapism lasting more than four hours constitutes a true emergency, as every hour of delay worsens the likelihood of preserving erectile function. Corporal blood gas analysis is the definitive diagnostic test, with dark blood and a pO2 below 40 mmHg confirming ischemic priapism. Phenylephrine is the intracavernosal sympathomimetic of choice, and epinephrine should be avoided due to its cardiovascular risks. For ischemic priapism persisting beyond 48 to 72 hours, early penile prosthesis placement is recommended over shunting because erectile dysfunction is nearly certain, and delayed implantation is technically challenging due to fibrosis. Non-ischemic priapism is not an emergency and can be managed electively with observation and selective embolization. In patients with sickle cell disease, adjunctive measures such as supplemental oxygen, intravenous hydration, alkalinization, and exchange transfusion support standard urologic management.

## References

1. Bivalacqua TJ, Perelman MA, Montague DK, et al. AUA guideline on the management of priapism. *J Urol*. 2022;207(4):754-763.  
2. Montague DK, Jarow J, Broderick GA, et al. American Urological Association guideline on the management of priapism. *J Urol*. 2003;170(4 Pt 1):1318-1324.  
3. Salonia A, Eardley I, Giuliano F, et al. European Association of Urology guidelines on priapism. *Eur Urol*. 2014;65(2):480-489.  
4. Burnett AL, Bivalacqua TJ. Priapism: current principles and practice. *Urol Clin North Am*. 2007;34(4):631-642.